| scholarly article | Q13442814 |
| P2093 | author name string | Leonard J | |
| Elder MJ | |||
| Dart JK | |||
| Bernauer W | |||
| P2860 | cites work | Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid | Q37311216 |
| Cicatricial pemphigoid and erythema multiforme | Q37945609 | ||
| Pemphigus and pemphigoid. A review of the advances made since 1964. | Q39812946 | ||
| Autoimmune phenomena in ocular cicatricial pemphigoid | Q44794099 | ||
| Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications | Q46202660 | ||
| Immunofluorescent studies in ocular cicatricial pemphigoid | Q68129695 | ||
| Cicatricial pemphigoid | Q68158346 | ||
| Immunopathology of cicatricial pemphigoid affecting the conjunctiva | Q68163528 | ||
| Corneal Infection in Mucosal Scarring Disorders and SjöUgren's Syndrome | Q68357982 | ||
| Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease | Q69368774 | ||
| Ocular cicatricial pemphigoid | Q70149761 | ||
| Immunosuppressive therapy for progressive ocular cicatricial pemphigoid | Q70249115 | ||
| Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid | Q70287560 | ||
| Benign mucous membrane pemphigoid | Q70601259 | ||
| The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis | Q70627886 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 292-296 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Progression of disease in ocular cicatricial pemphigoid | |
| P478 | volume | 80 |
| Q55268762 | Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid. |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q36195261 | Cicatricial pemphigoid and dry eye. |
| Q42122810 | Coexistence of ocular cicatricial pemphigoid with Stevens Johnson syndrome |
| Q37354234 | Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid |
| Q35215156 | Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom |
| Q89158617 | Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand |
| Q36238300 | Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom |
| Q34071975 | Laminins and human disease |
| Q77161223 | Mucous membrane pemphigoid |
| Q46661473 | Mucous membrane pemphigoid with ocular involvement. Part II: therapy |
| Q35841567 | NGF Modulates trkANGFR/p75NTR in αSMA-Expressing Conjunctival Fibroblasts from Human Ocular Cicatricial Pemphigoid (OCP). |
| Q64230980 | Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment |
| Q99240901 | Ocular cicatricial pemphigoid (Review) |
| Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
| Q37264280 | Ocular mucous membrane pemphigoid: diagnosis and management strategies. |
| Q39156883 | Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid. |
| Q92860765 | Role of immune cells in the ocular manifestations of pemphigoid diseases |
| Q39096598 | The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. |
| Q43842999 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid |
| Q34006160 | The role of the immune system in conjunctival wound healing after glaucoma surgery. |
| Q41359384 | Treatment strategies in mucous membrane pemphigoid |
| Q34996874 | Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis |
| Q80855750 | [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis] |
Search more.